1-(5-fluoro-1-octyl-1H-indol-3-yl)-N, N-dimethylmethanamine | 1263047-74-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 1-(5-fluoro-1-octyl-1H-indol-3-yl)-N, N-dimethylmethanamine
• 英文别名: 1-(5-fluoro-1-octyl-1H-indol-3-yl)-N,N-dimethylmethanamine；1-(5-fluoro-1-octylindol-3-yl)-N,N-dimethylmethanamine
• CAS: 1263047-74-0
• 化学式: C₁₉H₂₉FN₂
• 分子量: 304.451
• InChiKey: ZDOXSOGDUGYQHF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.3
• 重原子数：
  22
• 可旋转键数：
  9
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.58
• 拓扑面积：
  8.2
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  哌啶 、 聚合甲醛 、 1-(5-fluoro-1-octyl-1H-indol-3-yl)-N, N-dimethylmethanamine 在 溶剂黄146 作用下， 以 水 为溶剂， 反应 12.0h， 生成 5-fluoro-1-octyl-3-(piperidin-1-ylmethyl)-1H-indole
  参考文献：
  名称：

  Amphiphilic Indole Derivatives as Antimycobacterial Agents: Structure–Activity Relationships and Membrane Targeting Properties

  摘要：

  Antibacterials that disrupt cell membrane function have the potential to eradicate "persister" organisms and delay the emergence of resistance. Here we report the antimycobacterial activities of 4-fluoro and 6-methoxyindoles bearing a cationic amphiphilic motif represented by a lipophilic n-octyl side chain at position 1 and a positively charged azepanyl or 1,4-dioxa-8-azaspiro[4.5]decane moiety at position 3. These analogues exhibited balanced profiles of potency (Mycobacterium bovis BCG, M tuberculosis H37Rv), selective activity, solubility, and metabolic stability. Bacteriological mechanism of action investigations on a representative analogue revealed cell membrane permeabilization and depolarization in M bovis BCG. These membrane-related changes preceded cell death indicating that the loss in membrane integrity was not an epiphenomenon. Bactericidal activity was observed against both growing and nongrowing mycobacterial cultures. The analogue also upregulated cell envelope stress inducible promoters piniBAC and pclgR, implicating the involvement of envelope-related targets in its mode of action.

  DOI：

  10.1021/acs.jmedchem.6b01530
• 作为产物：
  描述：

  1-溴辛烷 在 sodium hydride 、 溶剂黄146 作用下， 以 水 、 N,N-二甲基甲酰胺 、 mineral oil 为溶剂， 反应 24.0h， 生成 1-(5-fluoro-1-octyl-1H-indol-3-yl)-N, N-dimethylmethanamine
  参考文献：
  名称：

  Amphiphilic Indole Derivatives as Antimycobacterial Agents: Structure–Activity Relationships and Membrane Targeting Properties

  摘要：

  Antibacterials that disrupt cell membrane function have the potential to eradicate "persister" organisms and delay the emergence of resistance. Here we report the antimycobacterial activities of 4-fluoro and 6-methoxyindoles bearing a cationic amphiphilic motif represented by a lipophilic n-octyl side chain at position 1 and a positively charged azepanyl or 1,4-dioxa-8-azaspiro[4.5]decane moiety at position 3. These analogues exhibited balanced profiles of potency (Mycobacterium bovis BCG, M tuberculosis H37Rv), selective activity, solubility, and metabolic stability. Bacteriological mechanism of action investigations on a representative analogue revealed cell membrane permeabilization and depolarization in M bovis BCG. These membrane-related changes preceded cell death indicating that the loss in membrane integrity was not an epiphenomenon. Bactericidal activity was observed against both growing and nongrowing mycobacterial cultures. The analogue also upregulated cell envelope stress inducible promoters piniBAC and pclgR, implicating the involvement of envelope-related targets in its mode of action.

  DOI：

  10.1021/acs.jmedchem.6b01530

文献信息

• [EN] SMALL MOLECULE INHIBITORS OF ISOPRENYLCYSTEINE CARBOXYL METHYLTRANSFERASE WITH POTENTIAL ANTICANCER ACTIVITY<br/>[FR] INHIBITEURS À PETITE MOLÉCULE D'ISOPRÉNYLCYSTÉINE CARBOXYL MÉTHYLTRANFÉRASE AVEC UNE ACTIVITÉ ANTICANCER POTENTIELLE
  申请人：UNIV SINGAPORE

  公开号：WO2011014128A1

  公开（公告）日：2011-02-03

  The present invention generally relates to inhibitors of isoprenylcysteine carboxyl methyltransferase (Icmt), in particularly to compounds that inhibit Icmt activity and pharmaceutical compositions thereof. The invention also relates to methods of disease treatment using the same.

  本发明通常涉及异戊二烯基半胱氨酸羧甲基转移酶（Icmt）的抑制剂，特别是抑制Icmt活性的化合物及其制药组合物。本发明还涉及使用相同的方法治疗疾病。
• SMALL MOLECULE INHIBITORS OF ISOPRENYLCYSTEINE CARBOXYL METHYLTRANSFERASE WITH POTENTIAL ANTICANCER ACTIVITY
  申请人：Leow Jo Lene

  公开号：US20120197014A1

  公开（公告）日：2012-08-02

  The present invention generally relates to inhibitors of isoprenylcysteine carboxyl methyltransferase (Icmt), in particularly to compounds that inhibit Icmt activity and pharmaceutical compositions thereof. The invention also relates to methods of disease treatment using the same.

  本发明通常涉及异戊二烯基半胱氨酸羧甲基转移酶（Icmt）的抑制剂，特别是抑制Icmt活性的化合物及其药物组合物。本发明还涉及使用这些抑制剂进行疾病治疗的方法。
• Small molecule inhibitors of isoprenylcysteine carboxyl methyltransferase with potential anticancer activity
  申请人：Leow Jo Lene

  公开号：US08742100B2

  公开（公告）日：2014-06-03

  The present invention generally relates to inhibitors of isoprenylcysteine carboxyl methyltransferase (Icmt), in particularly to compounds that inhibit Icmt activity and pharmaceutical compositions thereof. The invention also relates to methods of disease treatment using the same.

  本发明通常涉及异戊烯基半胱氨酸羧基甲基转移酶（Icmt）的抑制剂，特别是抑制Icmt活性的化合物及其制药组合物。本发明还涉及使用相同的疾病治疗方法。
• US8742100B2
  申请人：——

  公开号：US8742100B2

  公开（公告）日：2014-06-03